Company requirements under Canada's Access to Medicines Regime
To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Company requirements under Canada's Access to Medicines RegimeHTMLEnglish publication HTML
Company requirements under Canada's Access to Medicines RegimeHTMLFrench publication HTML